Denali Therapeutics Inc.
FUSION PROTEINS COMPRISING ENZYME REPLACEMENT THERAPY ENZYMES
Last updated:
Abstract:
Provided herein are fusion proteins that comprise an enzyme replacement therapy enzyme and an Fc region, as well as methods of using such proteins to treat a lysosomal storage disorder. Methods for transporting agents across the blood-brain barrier are also provided herein.
Status:
Application
Type:
Utility
Filling date:
23 Nov 2020
Issue date:
1 Jul 2021